DK2227488T6 - FVIII PEPTIDES AND THEIR USE for inducing tolerance in hemophilic - Google Patents

FVIII PEPTIDES AND THEIR USE for inducing tolerance in hemophilic Download PDF

Info

Publication number
DK2227488T6
DK2227488T6 DK08855772.3T DK08855772T DK2227488T6 DK 2227488 T6 DK2227488 T6 DK 2227488T6 DK 08855772 T DK08855772 T DK 08855772T DK 2227488 T6 DK2227488 T6 DK 2227488T6
Authority
DK
Denmark
Prior art keywords
ser
leu
ile
thr
arg
Prior art date
Application number
DK08855772.3T
Other languages
Danish (da)
English (en)
Other versions
DK2227488T3 (da
Inventor
David Wraith
Original Assignee
Apitope Int Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Int Nv filed Critical Apitope Int Nv
Application granted granted Critical
Publication of DK2227488T3 publication Critical patent/DK2227488T3/da
Publication of DK2227488T6 publication Critical patent/DK2227488T6/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK08855772.3T 2007-12-04 2008-12-03 FVIII PEPTIDES AND THEIR USE for inducing tolerance in hemophilic DK2227488T6 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides
PCT/GB2008/003996 WO2009071886A1 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs

Publications (2)

Publication Number Publication Date
DK2227488T3 DK2227488T3 (da) 2014-04-22
DK2227488T6 true DK2227488T6 (en) 2015-02-16

Family

ID=38982965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08855772.3T DK2227488T6 (en) 2007-12-04 2008-12-03 FVIII PEPTIDES AND THEIR USE for inducing tolerance in hemophilic

Country Status (25)

Country Link
US (1) US8445448B2 (cg-RX-API-DMAC7.html)
EP (1) EP2227488B3 (cg-RX-API-DMAC7.html)
JP (2) JP5501245B2 (cg-RX-API-DMAC7.html)
KR (1) KR101519840B1 (cg-RX-API-DMAC7.html)
CN (2) CN103709234B (cg-RX-API-DMAC7.html)
AU (1) AU2008332968B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0820143A2 (cg-RX-API-DMAC7.html)
CA (2) CA2707559C (cg-RX-API-DMAC7.html)
CY (1) CY1115168T1 (cg-RX-API-DMAC7.html)
DK (1) DK2227488T6 (cg-RX-API-DMAC7.html)
EA (1) EA019370B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP10010327A (cg-RX-API-DMAC7.html)
ES (1) ES2458315T7 (cg-RX-API-DMAC7.html)
GB (1) GB0723712D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20140344T4 (cg-RX-API-DMAC7.html)
IL (1) IL205780A (cg-RX-API-DMAC7.html)
MX (1) MX2010006084A (cg-RX-API-DMAC7.html)
MY (1) MY150995A (cg-RX-API-DMAC7.html)
NZ (1) NZ585217A (cg-RX-API-DMAC7.html)
PL (1) PL2227488T6 (cg-RX-API-DMAC7.html)
PT (1) PT2227488E (cg-RX-API-DMAC7.html)
SI (1) SI2227488T1 (cg-RX-API-DMAC7.html)
UA (1) UA101003C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009071886A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201002997B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2353347T3 (es) 2000-08-21 2011-03-01 Apitope Technology (Bristol) Limited Péptido.
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
SI2300497T1 (sl) * 2008-06-24 2013-02-28 Octapharma Ag Postopek za äťiĺˇäťenje koagulacijskega faktorja viii
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
CA2765657A1 (en) * 2009-06-16 2010-12-23 Tokai University Anti-gram-negative bacteria agent
CN104926947A (zh) 2010-10-27 2015-09-23 巴克斯特国际公司 用于免疫耐受性诱导和免疫诊断的fviii肽
CA2863329C (en) 2012-01-12 2023-01-03 Biogen Idec Ma Inc. Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy
EA036483B1 (ru) * 2012-11-12 2020-11-16 Эпитоп Интернэшнл Нв Пептиды, способные индуцировать толерантность к рекомбинантному fviii, содержащая их композиция, их применение и способ лечения гемофилии
GB201314052D0 (en) 2013-08-06 2013-09-18 Apitope Int Nv Peptides
CA3007262A1 (en) 2015-12-03 2017-06-08 Lucas James Thompson Modified chimeric receptors and related compositions and methods
KR20190091292A (ko) 2016-12-02 2019-08-05 바이오버라티브 테라퓨틱스 인크. 응고 인자에 대한 면역 내성 유도 방법
US12077607B2 (en) * 2021-09-23 2024-09-03 University Of Utah Research Foundation Functional and therapeutic effects of PAR4 cleavage by cathepsin G

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5930890A (en) * 1989-06-20 1991-01-08 Scripps Clinic And Research Foundation The phospholipid binding domain of factor viii
BR9806793A (pt) * 1997-01-22 2000-05-16 Univ Texas Processos e composições de fator tissular para coagulação e tratamento de tumores.
ES2353347T3 (es) * 2000-08-21 2011-03-01 Apitope Technology (Bristol) Limited Péptido.
WO2002060917A2 (en) * 2000-12-01 2002-08-08 Regents Of The University Of Minnesota Method to treat hemophilia
HUP0303171A2 (hu) * 2001-02-19 2003-12-29 Merck Patent Gmbh Csökkentett immunogenitású mesterséges fehérjék
AU2002312660A1 (en) * 2001-05-31 2002-12-16 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
AU2003232482A1 (en) * 2002-04-18 2003-10-27 Merck Patent Gmbh Modified factor viii
AU2005211725B2 (en) * 2004-02-09 2010-07-15 Human Genome Sciences, Inc. Albumin fusion proteins
WO2006003183A1 (de) 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin

Also Published As

Publication number Publication date
BRPI0820143A2 (pt) 2015-05-12
ES2458315T7 (es) 2015-02-18
NZ585217A (en) 2012-11-30
PT2227488E (pt) 2014-04-21
US20100323966A1 (en) 2010-12-23
SI2227488T1 (sl) 2014-06-30
MX2010006084A (es) 2010-06-23
AU2008332968A1 (en) 2009-06-11
EP2227488B3 (en) 2014-11-19
CY1115168T1 (el) 2016-12-14
ECSP10010327A (es) 2010-09-30
IL205780A0 (en) 2010-11-30
CN101889024A (zh) 2010-11-17
EA019370B1 (ru) 2014-03-31
CN103709234A (zh) 2014-04-09
PL2227488T3 (pl) 2014-07-31
EP2227488B1 (en) 2014-01-22
IL205780A (en) 2015-06-30
CA3005013A1 (en) 2009-06-11
KR101519840B1 (ko) 2015-05-18
EA201070681A1 (ru) 2010-10-29
HK1144292A1 (en) 2011-02-11
HRP20140344T4 (hr) 2015-07-31
AU2008332968B2 (en) 2014-03-20
UA101003C2 (uk) 2013-02-25
ES2458315T3 (es) 2014-04-30
CA2707559C (en) 2018-07-03
DK2227488T3 (da) 2014-04-22
CN101889024B (zh) 2014-04-23
JP5501245B2 (ja) 2014-05-21
US8445448B2 (en) 2013-05-21
ZA201002997B (en) 2011-07-27
JP2011505414A (ja) 2011-02-24
HRP20140344T1 (en) 2014-05-09
MY150995A (en) 2014-03-31
PL2227488T6 (pl) 2015-04-30
CN103709234B (zh) 2017-01-18
GB0723712D0 (en) 2008-01-16
WO2009071886A1 (en) 2009-06-11
CA2707559A1 (en) 2009-06-11
KR20100087346A (ko) 2010-08-04
JP6063402B2 (ja) 2017-01-18
EP2227488A1 (en) 2010-09-15
JP2014088440A (ja) 2014-05-15
CA3005013C (en) 2021-11-16

Similar Documents

Publication Publication Date Title
DK2227488T6 (en) FVIII PEPTIDES AND THEIR USE for inducing tolerance in hemophilic
DK2465523T3 (en) FVIII-derived peptides and their use in inducing tolerance in hemophiles
DK2917232T3 (en) FACTOR VIII DERIVATIVE PEPTIDES TO USE FOR TREATMENT OF HAEMOPHYL A
AU2014200237B2 (en) FVIII peptides and their use in tolerising haemophiliacs
HK1172240B (en) Fviii-derived peptides and their use in tolerising haemophiliacs
HK1172240A (en) Fviii-derived peptides and their use in tolerising haemophiliacs
HK1144292B (en) Fviii peptides and their use in tolerising haemophiliacs
HK1173358B (en) Fviii-derived peptides